Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

The efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for supplemental oxygen. The treatment had no significant effect on disease progression, independence from supplemental oxygen, or death.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-12, Vol.383 (24), p.2333-2344
Hauptverfasser: Stone, John H, Frigault, Matthew J, Serling-Boyd, Naomi J, Fernandes, Ana D, Harvey, Liam, Foulkes, Andrea S, Horick, Nora K, Healy, Brian C, Shah, Ruta, Bensaci, Ana Maria, Woolley, Ann E, Nikiforow, Sarah, Lin, Nina, Sagar, Manish, Schrager, Harry, Huckins, David S, Axelrod, Matthew, Pincus, Michael D, Fleisher, Jorge, Sacks, Chana A, Dougan, Michael, North, Crystal M, Halvorsen, Yuan-Di, Thurber, Tara K, Dagher, Zeina, Scherer, Allison, Wallwork, Rachel S, Kim, Arthur Y, Schoenfeld, Sara, Sen, Pritha, Neilan, Tomas G, Perugino, Cory A, Unizony, Sebastian H, Collier, Deborah S, Matza, Mark A, Yinh, Janeth M, Bowman, Kathryn A, Meyerowitz, Eric, Zafar, Amna, Drobni, Zsofia D, Bolster, Marcy B, Kohler, Minna, D’Silva, Kristin M, Dau, Jonathan, Lockwood, Megan M, Cubbison, Caroline, Weber, Brittany N, Mansour, Michael K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for supplemental oxygen. The treatment had no significant effect on disease progression, independence from supplemental oxygen, or death.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa2028836